b.aalto
TL2 · Ghent
Contributes reviews on supplier material. Based in Ghent.
Joined 9 February 2025 · last posted 4d
84 posts, newest first. Showing up to 150.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #81 · Practice › Interactions · 23 Jul 2026 · 5 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
-
How to ask a question when you cannot say why you are asking it Replied, post #49 · Start Here › How to Ask · 23 Jul 2026 · 5 likes Post #46 is right about the mechanism and I think understates the practical bit. If the answer you got does not fit your case, say which part does not fit rather than…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #41 · Sourcing › Regulatory · 19 Jul 2026 · 16 likes A compound in a compounding pathway in one country and unavailable in another is a common situation and produces most of the confusion here.
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #109 · Evidence › Preprints · 18 Jul 2026 · 0 likes Worth separating two things that post #106 runs together. Author track record is a weak signal and it is a signal. A group that has published carefully for years is a…
-
Alcohol: what is documented and what is folklore Replied, post #115 · Practice › Interactions · 16 Jul 2026 · 2 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #56 · Evidence › Journal club · 13 Jul 2026 · 0 likes Two claims get bundled together under SUSTAIN 6 and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one —…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #17 · Clinical › Prescriber conversations · 8 Jul 2026 · 2 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #60 · Access › Insurance & coverage · 7 Jul 2026 · 4 likes Everything in post #57 holds. The case it does not cover is the one I have. The claim about Prior authorisation upthread is stronger than its source supports. I have…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #71 · Outcomes › Progress reports · 6 Jul 2026 · 4 likes Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions. Two sources, same conclusion, and I…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #64 · Sourcing › Independent verification · 4 Jul 2026 · 0 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
GIP receptor agonism and the argument about direction — does this still hold? Replied, post #6 · Pharmacology › Receptor biology · 3 Jul 2026 · 6 likes Everything in post #2 holds. The case it does not cover is the one I have. Cross-reactivity and selectivity: the compounds are not perfectly selective for their target…
-
Search filters: what is missing Replied, post #75 · Meta › Site feedback · 30 Jun 2026 · 6 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #27 · Compounds › Semaglutide · 20 Jun 2026 · 0 likes On post #23 — agreed on the reasoning, with one qualification. The version of published dose-response for semaglutide that circulates here is a simplification of a…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #49 · Analytics › Home & field testing · 16 Jun 2026 · 15 likes Photographs of test results posted here are worth including with the lighting and the timing stated, because both change the apparent result of a colorimetric method…
-
Racemisation and why it is invisible to a mass measurement Replied, post #113 · Analytics › Impurities & related substances · 14 Jun 2026 · 27 likes Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
-
Tracking a shortage from primary sources rather than rumour Replied, post #26 · Access › Shortages · 28 May 2026 · 17 likes The version of tracking a shortage that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds,…
-
Batch numbers that do not match the vial label Replied, post #16 · Sourcing › Red flags · 14 May 2026 · 0 likes Post #14 put the caveat in the right place and I want to underline it. Where the same certificate image appears with different lot numbers, that is a documentation…
-
Revisiting: Absolute versus relative contraindications Replied, post #79 · Safety › Contraindications · 1 May 2026 · 15 likes Narrowing post #78, because the general version has more than one answer. Interaction-based contraindications are compound-pair specific and are the ones most often…
-
Why we ask for units every single time, with three examples of what goes wrong — what… Started this topic · Start Here › How to Ask · 29 Apr 2026 · 9 likes The question in the title: Why we ask for units every single time, with three examples of what goes wrong — what changed since I will give what I have already checked…
-
Amylin receptor signalling and satiety — what changed since Replied, post #69 · Pharmacology › Receptor biology · 27 Apr 2026 · 22 likes Receptor desensitisation and internalisation are real phenomena in vitro and their clinical relevance to these compounds is not established. That distinction gets lost…
-
Tracking intake honestly when appetite is absent Replied, post #5 · Nutrition & Training › Protein & intake · 21 Apr 2026 · 0 likes Adding the measurement that post #3 says would settle it. Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #40 · Compounds › Semaglutide · 20 Apr 2026 · 32 likes Worth separating two things that post #36 runs together. On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #67 · Clinical › Comorbidities · 14 Apr 2026 · 9 likes Taking post #65 at face value and following it one step further. Registry and observational data covering excluded populations is accumulating and is weaker evidence…
-
Run-in periods and the population they select Replied, post #98 · Evidence › Trials · 12 Apr 2026 · 14 likes Two people in this thread mean different things by run-in periods and are disagreeing about the definition while believing they are disagreeing about the facts. Worth…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #114 · Research Methods › N-of-1 designs · 28 Mar 2026 · 0 likes Post #113 put the caveat in the right place and I want to underline it. Withdrawal and reintroduction is the strongest design available to an individual, and it only…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #17 · Evidence › Journal club · 27 Mar 2026 · 4 likes A definition problem is doing most of the work in this indirect comparison discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what…
-
Dizziness on standing and the electrolyte explanation Replied, post #8 · Practice › Side effects · 21 Mar 2026 · 23 likes The number people quote for dizziness on standing is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #31 · Evidence › Trials · 15 Mar 2026 · 8 likes Post #29 and I disagree about the size of the effect, not about the direction. A methods point on Composite endpoints rather than a substantive one: if the comparison…
-
Grapefruit: why this class is not the class that cares Replied, post #26 · Practice › Interactions · 10 Mar 2026 · 7 likes Taking post #25 at face value and following it one step further. What I can speak to on grapefruit is narrow, so I will keep it narrow rather than generalising from it.…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #61 · Clinical › Bloodwork · 8 Mar 2026 · 31 likes Reference intervals has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
The lowest dose that does anything: is that a real question? Replied, post #33 · Practice › Dosing & titration · 3 Mar 2026 · 4 likes Helpful, and easy to find again, which is half of what a good reply is.
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #72 · Analytics › Impurities & related substances · 20 Feb 2026 · 12 likes Answering the question post #68 raises rather than the one it answers. Genuine question rather than a rhetorical one: has anyone here actually observed rising…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #78 · Access › International · 28 Jan 2026 · 0 likes An update on my earlier Language barriers in accessing post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #49 · Meta › Site feedback · 20 Jan 2026 · 26 likes Worth separating two things that post #47 runs together. The arithmetic on topic list is the easy part and it is where the errors are, which is an uncomfortable…
-
A calculator that gives a right answer to the wrong question Replied, post #2 · Data & Tools › Calculators · 19 Jan 2026 · 11 likes The opening post describes the usual case. This is about the unusual one. Reporting bugs: if you notice a calculator giving wrong results, report it in this…
-
A parcel stationary at a customs facility for nine days Replied, post #18 · Sourcing › Logistics · 7 Jan 2026 · 3 likes I would put moderate confidence on the mainstream reading of parcel stationary and no more. That is not scepticism for its own sake; it is where the sourcing actually…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #39 · Practice › Side effects · 6 Jan 2026 · 1 like The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Tracking a preprint to publication: a worked example Replied, post #24 · Evidence › Preprints · 1 Dec 2025 · 17 likes Confirming post #21 from a second method, which matters more than confirming it from a second person. A preprint with the data and code attached is frequently more…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #8 · Clinical › Bloodwork · 9 Nov 2025 · 14 likes Coming back to post #4, because the follow-up matters more than the original answer. Glycaemic markers integrate over different periods. A point glucose and a…
-
Search filters: what is missing Replied, post #2 · Meta › Site feedback · 8 Nov 2025 · 24 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
-
Cross-border purchase rules within the EU Replied, post #30 · Regional › European Union · 28 Oct 2025 · 10 likes I read post #26 twice before replying, because I had assumed the opposite. Small methodological point on cross-border purchase rules within: repeating a measurement is…
-
A 40-week log with the measurement method stated Replied, post #80 · Outcomes › Progress reports · 27 Oct 2025 · 0 likes This follows post #77 rather than contradicting it. 40-week log is worth one more sentence than it usually gets, and the sentence is the one about how the number was…
-
Realistic expectations for strength while losing weight quickly Replied, post #29 · Nutrition & Training › Resistance training · 18 Oct 2025 · 2 likes Where I would push back on the realistic expectations for strength consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
How to read a forest plot, properly, from scratch Replied, post #38 · Evidence › Trials · 9 Oct 2025 · 1 like I read post #36 twice before replying, because I had assumed the opposite. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #76 · Evidence › Journal club · 9 Oct 2025 · 2 likes I had written a reply contradicting post #75 and deleted it. Here is what survived. The figures usually contain the finding and the text usually contains the…
-
Documentation that appears only after payment Replied, post #43 · Sourcing › Red flags · 8 Oct 2025 · 23 likes On documentation I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads…
-
Payment method and the leverage it gives you, ranked Replied, post #39 · Sourcing › Payments · 19 Sep 2025 · 27 likes This is the answer, and the reason it is the answer is the more useful part.
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #39 · Practice › Storage & stability · 15 Sep 2025 · 4 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. Worth saying I have only my own numbers…
-
Comparing two chromatograms from different laboratories, properly Replied, post #9 · Analytics › HPLC & UHPLC · 8 Sep 2025 · 0 likes A shallow gradient resolves close-eluting species that a steep one merges. Two honest laboratories running different gradients can report genuinely different purities…
-
What a 2 ppm match establishes, and what it does not Replied, post #46 · Analytics › Mass spectrometry · 29 Aug 2025 · 5 likes What would change my mind on 2 ppm match is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #114 · Evidence › Journal club · 25 Aug 2025 · 0 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. Written in…
-
When a preprint is the best available evidence and we say so Replied, post #90 · Evidence › Preprints · 23 Aug 2025 · 26 likes Nothing to add, except that this is the answer I would give if asked.
-
Travel coolers and how long they really hold Replied, post #36 · Devices › Cold chain · 3 Aug 2025 · 0 likes Checked the travel coolers claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
-
History of disordered eating and why it changes the conversation Replied, post #6 · Clinical › Special populations · 26 Jul 2025 · 29 likes That is the distinction I keep failing to hold on to. Written down now.
-
Managing an unplanned gap in supply — what changed since Replied, post #24 · Access › Shortages · 25 Jul 2025 · 24 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
A preprint whose numbers changed substantially at publication — what changed since Started this topic · Evidence › Preprints · 25 Jul 2025 · 9 likes On the subject in the title: A preprint whose numbers changed substantially at publication — what changed since Working notes rather than a conclusion. A preprint…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #137 · Compounds › Cagrilintide & amylin analogues · 19 Jun 2025 · 1 like Answering the question post #133 raises rather than the one it answers. Anyone submitting this for independent testing should say in the submission that it is an amylin…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #45 · Evidence › Journal club · 19 Jun 2025 · 6 likes Post #41 put the caveat in the right place and I want to underline it. CagriSema phase 2 combination paper has been discussed here with more heat than it deserves,…
-
Lyophilisation and why the cake looks the way it does Replied, post #3 · Pharmacology › Formulation chemistry · 26 May 2025 · 16 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. Sterility and stability are separate properties requiring separate…
-
Reading a supplier's product description as a marketing document Replied, post #24 · Compounds › Other compounds · 19 May 2025 · 0 likes Where I part company with post #22, and it is a narrow parting. Fragment compounds — where the material is part of a larger natural protein — should be identified by…
-
Certificates issued by the seller versus by a laboratory Replied, post #61 · Analytics › COA interpretation · 25 Apr 2025 · 25 likes Picking up post #58: that is the part I would want checked first. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures…
-
Asking about a compound your prescriber has not heard of Replied, post #9 · Clinical › Prescriber conversations · 2 Apr 2025 · 4 likes Post #5 put the caveat in the right place and I want to underline it. Asking about monitoring: understand what lab work will be done, how often, and what you will be…
-
Units, standards, and other things that quietly hold the world together Replied, post #10 · Lounge › Off topic · 2 Apr 2025 · 2 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute. Second-hand, so…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #126 · Compounds › Semaglutide · 31 Mar 2025 · 5 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #26 · Practice › Interactions · 26 Mar 2025 · 0 likes Having read the whole delayed gastric emptying and oral thread before replying: the question in the first post has not actually been answered yet, and three of us have…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #43 · Access › Pricing · 24 Mar 2025 · 17 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #34 · Evidence › Journal club · 10 Mar 2025 · 13 likes I read the earlier replies on SURMOUNT-OSA twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #11 · Sourcing › Vendor reports · 21 Feb 2025 · 13 likes The maintainers will ask for missing fields rather than rejecting a report. Filling them in afterwards is normal and nobody minds. I have said this before in a thread…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #104 · Compounds › Semaglutide · 11 Feb 2025 · 0 likes What would change my mind on Semaglutide half-life is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #17 · Compounds › Tirzepatide · 7 Feb 2025 · 0 likes SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed diabetes dose at the time and it was not the highest dose available in…
-
Identical chromatograms across two different lots Replied, post #86 · Sourcing › Red flags · 4 Feb 2025 · 11 likes Keep the two claims separate. "The result on this lot did not match the certificate" is a report that can be checked. "This supplier is dishonest" is an allegation…
-
Cost per milligram, computed honestly across formats — the long version Started this topic · Access › Pricing · 29 Jan 2025 · 2 likes Cost per milligram, computed honestly across formats — the long version Writing it up because I had to work it out twice and would rather nobody else did. Documenting…
-
Why the Start Here categories exist, and what they are not for — one year on Replied, post #10 · Start Here › Welcome · 29 Jan 2025 · 31 likes A methods point on Start rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #75 · Compounds › Tirzepatide · 7 Dec 2024 · 5 likes Tirzepatide's half-life of roughly five days means steady state is approached in about three weeks rather than four. That is a real difference from semaglutide and it…
-
Washout with a one-week half-life: the arithmetic Replied, post #13 · Research Methods › N-of-1 designs · 24 Nov 2024 · 2 likes A photograph or a device reading is a harder record than a recollection, and where one is available it should be the record.
-
Two sessions a week versus four: what the evidence supports Replied, post #6 · Nutrition & Training › Resistance training · 16 Nov 2024 · 0 likes I read post #4 twice before replying, because I had assumed the opposite. Anybody returning after a break should expect to start lower than they left, and expecting…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #71 · Evidence › Journal club · 12 Oct 2024 · 0 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
-
Second pass at: Reimbursement variation across member states Replied, post #11 · Regional › European Union · 20 Sep 2024 · 22 likes The public assessment report published at authorisation is one of the best free technical documents available on any of these compounds and it is rarely cited here.…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #58 · Nutrition & Training › Hydration & electrolytes · 25 Aug 2024 · 8 likes The most useful reply I ever got about Sodium was a request to state my units. It sounds like pedantry and it has saved me twice.
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #24 · Analytics › Mass spectrometry · 14 Aug 2024 · 25 likes Thank you for the correction. I would rather find out here than later.
-
The mass-error checker and its intended scope Replied, post #168 · Data & Tools › Calculators · 30 Jul 2024 · 0 likes Post #164 describes the usual case. This is about the unusual one. A methods point on mass-error checker rather than a substantive one: if the comparison is not like…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #25 · Practice › Dosing & titration · 7 Jul 2024 · 2 likes Adding the measurement that post #22 says would settle it. Worth stating the null on Splitting a weekly dose before we explain it: the observation may be nothing. That…
-
The mass-error checker and its intended scope Replied, post #83 · Data & Tools › Calculators · 29 Jun 2024 · 12 likes Filing a mild objection to the consensus on mass-error checker. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
Assessing a warm arrival: the decision process — one year on Replied, post #84 · Sourcing › Logistics · 31 May 2024 · 0 likes A methods point on Assessing a warm arrival rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in…